Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553825 · ClinicalTrials.gov registry record
Assessment of Patient Experience During Treatment for Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 116
- Enrollment target
NCT01553825: Completed study, sponsored by Stanford University.
NCT01553825 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01553825 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Assessing the mindset of cancer patients will help us better understand which patients are having difficulty dealing with the diagnosis and treatment that may not otherwise be fully appreciated by their physicians. By identifying such patients, we may then be able to design and implement strategies that can help improve their coping skills both during the treatment as well as after the completion of treatment. In addition to addressing physical concerns and symptoms, this approach will help address the overall emotional impact of a cancer diagnosis as more patients are living as cancer survivors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2012-03 |
| Est. Completion | 2020-01-09 |
What the finished NCT01553825 record still lists
NCT01553825 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01553825 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01553825 about?
NCT01553825 is a clinical study titled "Assessment of Patient Experience During Treatment for Cancer". Assessing the mindset of cancer patients will help us better understand which patients are having difficulty dealing with the diagnosis and treatment that may not otherwise be fully appreciated by their physicians. By identifying such patients, we may then be able to design and implement strategies ...
What is the current status of trial NCT01553825?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2012-03. Estimated completion is 2020-01-09.
Who is sponsoring clinical trial NCT01553825?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia